CRL · News · 20260809N
Guidance and Outlook
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-09 · Importance 51 · Surprise 60 · In source text
Charles River Laboratories reduced its 2026 GAAP earnings guidance, indicating a lower expected full-year earnings outcome than previously communicated. The company also reported a quarterly net loss, reversing quarterly profitability. The report does not provide the revised guidance figures or the net-loss amount, limiting assessment of the changes against the company’s materiality thresholds.
Key facts
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. recently cut its 2026 GAAP earnings guidance. source
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported a quarterly net loss. source
- One valuation narrative in the article suggests CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s stock is 14.7% undervalued based on primate supply constraints. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | negative | probable | — | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. recently cut its 2026 GAAP earnings guidance. |